System zur Abgabe einer Tobramycin-Formulierung
European patent · EP1320355 · Deleted
Register entry
- Publication number
- EP1320355
- Application number
- EP02771857
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- May 17, 2002
- Published
- Jun 25, 2003
- Granted
- Apr 5, 2006
- Deleted
- Apr 5, 2006
- Reason
- Revoked in opposition
- IPC classes
- A61K 9/00 (2006.01)A61K 9/12 (2006.01)A61K 31/7036 (2006.01)
- Priority
- US 292234 P 18.05.2001
- PCT application
- PCT/US2002/015999 17.05.2002
- PCT publication
- WO2002/094217 28.11.2002
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 25, 2024
Change
Published in Swissreg on 25.06.2024
- Jul 9, 2010
Change
Published in Swissreg on 09.07.2010
- Feb 29, 2008
Address changed
- Owner
- CHIRON CORPORATION, 4560 Horton Street, Emeryville, California 94608-2916, USA → NOVARTIS VACCINES & DIAGNOSTICS, INC., 4560 Horton Street, Emeryville, CA 94608-2916, USA
Published in +pat+ No 4 in 2008
- Jul 31, 2006
Agent entered
- Representative
- Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich
Published in +pat+ No 14 in 2006
- Apr 13, 2006
Granted
Published in +pat+ No 7 in 2006
Parties
Inventor
SPEIRS, Robert, J.
Lynwood, WA 98037, US
SCHAEFFLER, Barbara, A.
Seattle, WA 98103, US
CHALLONER, Peter, B.
Seattle, WA 98109, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.